Daniels, Tracey E., Lai, L.Y., Cameron, S., Dawson, S., Farrell, S., Hutchings, M., Sandler, R.D., Whitehouse, J., Withers, N., Baker, L., Bourke, S.J., Dooney, M., Saba, T., Pasteur, M., Waine, D., Derry, D., Allenby, M., Bateman, K., Pilkington, E., Warnock, L., Gledhill, H., Chapman, S., Galey, P., Choyce, J., Pickering, N., Dewar, J., Fitch, G., McGowan, A., Thomas, R., Shiferaw, D., Dowdell, C., Morgan, H., Anderson, A., Barnett, T., Thomas, M., Dale, W., Barlow, L., Ballinger, K., Lee, K., Robson, N., Wildman, M.J. and Hoo, Z.H. (2023) P147 “What options are available for those not able to take current CFTR modulators?”: an answer hidden in plain sight? Journal of Cystic Fibrosis, 22. S110.

Full text not available from this repository.

Item Type:	Article
Status:	Published
DOI:	https://doi.org/10.1016/S1569-1993(23)00522-2
School/Department:	School of Science, Technology and Health
URI:	https://ray.yorksj.ac.uk/id/eprint/8057

University Staff: Request a correction | RaY Editors: Update this record